Desmocollin-1 plays a role in breast cancer cell migration,
invasion and metastasis and is modulated by parthenolide

a 2020

Desmocollin-1 plays a role in breast cancer cell migration, invasion and metastasis and is modulated by parthenolide

LAPČÍK, Petr, Petr ŠULC, Jakub FAKTOR, Lucia JANÁČOVÁ, Kateřina JÍLKOVÁ et. al.

Základní údaje

Originální název

Desmocollin-1 plays a role in breast cancer cell migration, invasion and metastasis and is modulated by parthenolide

Název česky

Desmocollin-1 hraje roli v buněčné migraci, invazivitě a tvorbě metastáz nádorů prsu a je modulovaný parthenolidem

Autoři

LAPČÍK, Petr, Petr ŠULC, Jakub FAKTOR, Lucia JANÁČOVÁ, Kateřina JÍLKOVÁ, David POTĚŠIL, Pavla BOUCHALOVÁ, Petr MÜLLER a Pavel BOUCHAL

Vydání

19th Human Proteome Organization World Congress, HUPO Connect 2020, Online, 19..10-22.10.2020, in Book of Abstracts, p. 56, 2020

Další údaje

Typ výsledku

Konferenční abstrakt

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Příznaky

Mezinárodní význam

Změněno: 9. 2. 2022 16:40, Mgr. Petr Lapčík, Ph.D.

Anotace

V originále

Introduction: Desmocollin-1 (DSC1) is a desmosomal protein playing a role in cell-cell adhesion and tight cell junctions. Recently [1] we identified increased levels of DSC1 in lymph node positive vs. negative primary luminal A tumors. Therefore, we focused on the DSC1 role in molecular mechanisms of lymph node metastasis in luminal A breast cancer and its possible therapeutic modulation. Methods: A stably transduced, DSC1 overexpressing luminal A breast cancer cell line (MCF7-DSC1-GFP) was generated. Transwell assay and atomic force microscopy were used to study effect of DSC1 overexpression on MCF7 cell migration, invasion, and morphology. Effect of potential DSC1 inhibitors selected in Gene Set Enrichment Analysis (GSEA) of mRNA microarray data set of 341 luminal A tumors was analyzed using western blots and flow cytometry. Quantitative total proteome analysis and pull-down assays were performed in direct data independent acquisition mode on Orbitrap Fusion Lumos mass spectrometer with data analysis in Spectronaut and GSEA. Results: DSC1 overexpression increased migration and invasion capacity, decreased height of MCF7 cells and led to enrichment of proteins involved in cell cycle regulation, including CDK2, MCM2-7, IBP5 and LACRT in the total proteome analysis (p<0.05). Parthenolide, the best performing inhibitor, decreased DSC1 protein levels in MCF7-DSC1-GFP cells, directed them to apoptosis and decreased levels of cell cycle-associated proteins. DSC1 interaction partners included cadherins, protocadherins and tyrosine kinases ERBB2 and ERBB3. Of these, DSC1-ERBB3 interaction was affected by parthenolide (p<0.05). Conclusions: Our systems biology data indicate that DSC1 is connected to cell migration, invasion and cell cycle regulation in luminal A breast cancer cells, and can be effectively modulated by parthenolide, directing the cells to apoptosis. This work was supported by the Ministry of Health of the Czech Republic, grant No. NV19-08-00250. References: 1. Faktor, J. et al., Proteomics 2019, 19, 1900073.

Návaznosti

MUNI/A/1252/2019, interní kód MU

Název: Podpora biochemického výzkumu v roce 2020

Investor: Masarykova univerzita, Podpora biochemického výzkumu v roce 2020, DO R. 2020_Kategorie A - Specifický výzkum - Studentské výzkumné projekty

NV19-08-00250, projekt VaV

Název: Proteotypová klasifikace renálního karcinomu ve vztahu k prognóze a terapeutické odpovědi

Investor: Ministerstvo zdravotnictví ČR, Proteotypová klasifikace renálního karcinomu ve vztahu k prognóze a terapeutické odpovědi

Citovat

LAPČÍK, Petr, Petr ŠULC, Jakub FAKTOR, Lucia JANÁČOVÁ, Kateřina JÍLKOVÁ, David POTĚŠIL, Pavla BOUCHALOVÁ, Petr MÜLLER a Pavel BOUCHAL. Desmocollin-1 plays a role in breast cancer cell migration, invasion and metastasis and is modulated by parthenolide. In 19th Human Proteome Organization World Congress, HUPO Connect 2020, Online, 19..10-22.10.2020, in Book of Abstracts, p. 56. 2020.

@proceedings{1707996,
   author = {Lapčík, Petr and Šulc, Petr and Faktor, Jakub and Janáčová, Lucia and Jílková, Kateřina and Potěšil, David and Bouchalová, Pavla and Müller, Petr and Bouchal, Pavel},
   booktitle = {19th Human Proteome Organization World Congress, HUPO Connect 2020, Online, 19..10-22.10.2020, in Book of Abstracts, p. 56},
   title = {Desmocollin-1 plays a role in breast cancer cell migration, invasion and metastasis and is modulated by parthenolide},
   url = {https://hupo2020.org/wp-content/uploads/2020/10/HUPO-Connect-2020-Abstract_Book_2020.10.15-NR.pdf},
   year = {2020}
}

TY  - CONF
ID  - 1707996
AU  - Lapčík, Petr - Šulc, Petr - Faktor, Jakub - Janáčová, Lucia - Jílková, Kateřina - Potěšil, David - Bouchalová, Pavla - Müller, Petr - Bouchal, Pavel
PY  - 2020
TI  - Desmocollin-1 plays a role in breast cancer cell migration, invasion and metastasis and is modulated by parthenolide
UR  - https://hupo2020.org/wp-content/uploads/2020/10/HUPO-Connect-2020-Abstract_Book_2020.10.15-NR.pdf
N2  - Introduction: Desmocollin-1 (DSC1) is a desmosomal protein playing a role in cell-cell adhesion and tight cell junctions. Recently [1] we identified increased levels of DSC1 in lymph node positive vs. negative primary luminal A tumors. Therefore, we focused on the DSC1 role in molecular mechanisms of lymph node metastasis in luminal A breast cancer and its possible therapeutic modulation. Methods: A stably transduced, DSC1 overexpressing luminal A breast cancer cell line (MCF7-DSC1-GFP) was generated. Transwell assay and atomic force microscopy were used to study effect of DSC1 overexpression on MCF7 cell migration, invasion, and morphology. Effect of potential DSC1 inhibitors selected in Gene Set Enrichment Analysis (GSEA) of mRNA microarray data set of 341 luminal A tumors was analyzed using western blots and flow cytometry. Quantitative total proteome analysis and pull-down assays were performed in direct data independent acquisition mode on Orbitrap Fusion Lumos mass spectrometer with data analysis in Spectronaut and GSEA. Results: DSC1 overexpression increased migration and invasion capacity, decreased height of MCF7 cells and led to enrichment of proteins involved in cell cycle regulation, including CDK2, MCM2-7, IBP5 and LACRT in the total proteome analysis (p<0.05). Parthenolide, the best performing inhibitor, decreased DSC1 protein levels in MCF7-DSC1-GFP cells, directed them to apoptosis and decreased levels of cell cycle-associated proteins. DSC1 interaction partners included cadherins, protocadherins and tyrosine kinases ERBB2 and ERBB3. Of these, DSC1-ERBB3 interaction was affected by parthenolide (p<0.05). Conclusions: Our systems biology data indicate that DSC1 is connected to cell migration, invasion and cell cycle regulation in luminal A breast cancer cells, and can be effectively modulated by parthenolide, directing the cells to apoptosis. This work was supported by the Ministry of Health of the Czech Republic, grant No. NV19-08-00250. References: 1. Faktor, J. et al., Proteomics 2019, 19, 1900073.
ER  -

LAPČÍK, Petr, Petr ŠULC, Jakub FAKTOR, Lucia JANÁČOVÁ, Kateřina JÍLKOVÁ, David POTĚŠIL, Pavla BOUCHALOVÁ, Petr MÜLLER a Pavel BOUCHAL. Desmocollin-1 plays a role in breast cancer cell migration, invasion and metastasis and is modulated by parthenolide. In \textit{19th Human Proteome Organization World Congress, HUPO Connect 2020, Online, 19..10-22.10.2020, in Book of Abstracts, p. 56}. 2020.

Podrobný výpis o publikaci